Journal of Chemical Information and ModelingBioinformaticsPeer-reviewed journal article
B-SIDER: Computational Algorithm for the Design of Complementary β-sheet Sequences
Abstract
The {beta}-sheet is an element of protein secondary structure, and intra-/inter-molecular {beta}-sheet interactions play pivotal roles in biological regulatory processes including scaffolding, transporting, and oligomerization. In nature, a {beta}-sheet formation is tightly regulated because dysregulated {beta}-stacking often leads to severe diseases such as Alzheimers, Parkinsons, systemic amyloidosis, or diabetes. Thus, the identification of intrinsic {beta}-sheet forming propensities can provide valuable insight into protein designs for the development of novel therapeutics. However, structure-based design methods may not be generally applicable to such amyloidogenic peptides mainly owing to high structural plasticity and complexity. Therefore, an alternative design strategy based on complementary sequence information is of significant importance. Herein, we developed a database search method called B-SIDER for the design of complementary {beta}-strands. This method makes use of the structural database information and generates query-specific score matrices. The discriminatory power of the B-SIDER score function was tested on representative amyloidogenic peptide substructures against a sequence-based score matrix (PASTA2.0) and two popular ab initio protein design score functions (Rosetta and FoldX). B-SIDER is able to distinguish wild-type amyloidogenic {beta}-strands as favored interactions in a more consistent manner than other methods. B-SIDER was prospectively applied to the design of complementary {beta}-strands for a splitGFP scaffold. Three variants were identified to have stronger interactions than the original sequence selected through a directed evolution, emitting higher fluorescence intensities. Our results indicate that B-SIDER can be applicable to the design of other {beta}-strands, assisting in the development of therapeutics against disease-related amyloidogenic peptides.
- assay: protein sequence
- research focus: protein design
- research focus: benchmarking
- research focus: sequence-to-function modeling
- research focus: drug response / drug discovery
- approach: statistical model
- Citations
- 5
- FWCI
- 0.17
- Field percentile
- 45th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Design of amyloidogenic peptide traps
Danny D. Sahtoe, Ewa A. Andrzejewska, … David A. Baker·Nature Chemical BiologyPeer-reviewed·Mar 19, 2024
- De novo Design of Peptides that Bind Specific Conformers of α-Synuclein
H. Wallace, H. Yang, … W. DeGrado·bioRxiv·Nov 14, 2023
- Design of parallel ????-sheet nanofibrils using Monte-Carlo search, coarse-grained simulations, and experimental testing
S. Sarma, T. R. Sudarshan, … C. K. Hall·bioRxiv·Nov 9, 2023
- In silico identification of novel peptides as potential modulators of Aβ42 Amyloidogenesis
Kavita Kundal, Santhosh Paramasivam, … Nandini Sarkar·bioRxiv·Apr 20, 2022
- Design of linear and cyclic peptide binders of different lengths from protein sequence information
Qiuzhen Li, Efstathios Nikolaos Vlachos, Patrick Bryant·bioRxiv·Jun 20, 2024
- The AWSEM-Amylometer: Predicting Amyloid Propensity And Fibril Topology Using An Optimized Folding Landscape Model
M. Chen, N. Schafer, … P. G. Wolynes·bioRxiv·May 17, 2017